Navigation Links
Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying Therapeutic Discovery Project Program
Date:11/3/2010

SEATTLE, Nov. 3, 2010 /PRNewswire/ -- Omeros Corporation (Nasdaq: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has been awarded non-taxable grants totaling approximately $1.7 million under the Qualifying Therapeutic Discovery Project (QTDP) included in the Patient Protection and Affordable Health Care Act of 2010.

To be eligible to receive a grant award under the QTDP program, projects must show reasonable potential to result in new therapies to treat areas of unmet medical need or prevent, detect, or treat chronic or acute disease and conditions; to reduce long-term health care costs in the United States; or to significantly advance the goal of curing cancer within 30 years. Grant applications were reviewed by both the Treasury Department and the Department of Health and Human Services.

About Omeros Corporation

Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery(TM) platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five ongoing clinical development programs, including four from its PharmacoSurgery(TM) platform, the most advanced of which is in a Phase 3 clinical program, and one from its Addiction program. Omeros may also have the near-term capability, through its GPCR program, to add wholly new drug targets to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of antibody and small-molecule preclinical programs targeting inflammation and cent
'/>"/>

SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Omeros Appoints David A. Mann to its Board of Directors
2. Affitech and Omeros Enter Into Antibody Discovery and Development Agreement
3. Omeros and BlueCrest Announce $20 Million Debt Facility
4. Omeros Announces Results from a Phase 1 Study of OMS201 for Use During Urological Surgery
5. Omeros Awarded Grant from The Michael J. Fox Foundation to Evaluate Novel Parkinsons Disease Target
6. Omeros Appoints New Vice President of Clinical Development
7. Omeros Announces Positive Clinical Results of Phase 1/Phase 2 Trial of OMS302 for Use During Ophthalmologic Surgery
8. Omeros Commences Initial Public Offering of Common Stock
9. Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights
10. Omeros to Webcast Presentation at Deutsche Bank 35th Annual Health Care Conference
11. Omeros To Webcast Presentation at Ninth Annual Needham Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... CAMBRIDGE, England , May 24, 2013 ... von Mundipharma angefertigt – Bei der ... Version , 91 % der Teilnehmer einer ... obwohl nur 20 % laut GINA [*] -Definition [1] ... zeigt, dass Menschen mit Asthma generell einer von vier ...
(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...
(Date:5/23/2013)... , May 23, 2013  Rahal Letterman Lanigan Racing ... cord blood stem cell banking and therapeutics, announced today ... No. 16 Acorn Stairlifts Indy car driven by ... remainder of the IZOD IndyCar 2013 season.   ... work to support awareness of umbilical cord blood banking ...
(Date:5/23/2013)... , May 23, 2013  Saddleback Memorial Medical Center ... became the first hospital on the West Coast to ... new surgical option provides women with a state-of-the-art, minimally ... Marc Winter , M.D., a highly regarded ... and medical director of minimally invasive surgery at Saddleback ...
Breaking Biology Technology:Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 2Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 3Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 4Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 5Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 6Neue Forschungsergebnisse zeigen Verbindung zwischen suboptimaler Asthmaversorgung und Patienteneinstellungen in Europa auf 7Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3
... (Euronext: AMT), a leader in the field of human ... for personal reasons retire,as chief executive officer, effective February ... and co-founder of the company, has,been named chief executive ... Since Ronald Lorijn started in 2005, AMT changed ...
... Fred Hutchinson Cancer Research Center,s,stem-cell transplant program at ... only two transplant programs nationwide that consistently outperformed,the ... according,to an independent report that assessed 122 transplant ... The Center for International Blood and Marrow ...
... products are featured in Genetic Engineering News for delivering the promise ... ... Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria,s product line ... News (GEN, Jan 15, 2009 pp 32-34). The article, entitled ...
Cached Biology Technology:AMT CEO Ronald Lorijn Steps Down 2AMT CEO Ronald Lorijn Steps Down 3Transplant Program Tops in Expected One-Year Survival Rate 2InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication 2
(Date:5/22/2013)... technique that can detect molecular variants in chemical mixtures ... the most important, though time-consuming, processes in analytical chemistry. ... Nature , post-doctoral researcher David Patterson, Professor of Physics ... for Free-Electron Laser Science (CFEL) in Hamburg, Germany developed ... identify molecular variants apart, and to determine how much ...
(Date:5/22/2013)... of potential environmental and human health effects from ... year has led scientists to recommend stronger government ... lithium-ion (Li-ion) battery materials. That,s the conclusion of ... Environmental Science & Technology . , Oladele A. ... have become mainstays for powering everything from smart ...
(Date:5/22/2013)... 22, 2013 Early screening for prostate cancer could ... is for women, thanks to UC Irvine research published ... Society . , After more than a decade of ... clearly identify clinically usable markers for prostate cancer in ... sooner, with greater accuracy and at dramatically lower cost. ...
Breaking Biology News(10 mins):Detecting mirror molecules 2Detecting mirror molecules 3UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... LAFAYETTE, Ind. - A group of Purdue University researchers has ... materials, such as nutrients and drug treatments, to move in ... Jue Chen, an associate professor of biological sciences, obtained a ... closes pathways through the protective cellular membrane. The gates, operated ...
... CONRAD Program of the Eastern Virginia Medical School today announced ... Bill & Melinda Gates Foundation to develop microbicides for HIV ... total of $65 million to CONRAD for microbicide research. ... combination microbicides, research on novel and improved in vitro and ...
... at Duke University have created the first map of imprinted ... Rosetta stone a form of artificial intelligence called machine ... The study revealed four times as many imprinted genes as ... of the December 3 issue of Genome Research. In ...
Cached Biology News:Purdue researchers obtain a snapshot clarifying how materials enter cells 2Purdue researchers obtain a snapshot clarifying how materials enter cells 3CONRAD receives $28.5M Gates Foundation grant for HIV prevention research 2Duke scientists map imprinted genes in human genome 2Duke scientists map imprinted genes in human genome 3
...
Anti-Human Factor XIII HRPO (Polyclonal) (sheep IgG)...
Recognizes the 41 and 43 kDa G-proteins present in liver plasma membranes and Gq/11alpha expressed in the Sf9 insect cell expression system. Negative for recombinant G(I)alpha subtypes....
Rabbit polyclonal to Flagellin ( Abpromise for all tested applications). Antigen: Synthetic peptide from the flagellin C terminal domain of Burkholderia pseudomallei....
Biology Products: